Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ASPN vs HDSN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
HDSN Captures Overall Composite Edge (53.2 HOLD vs 46.3 HOLD), While ASPN Leads 4–2 on Growth & Valuation Pillars
HDSN Overall Winner
6-Pillar Tally: ASPN 4 – 2 HDSN
Matrix Metrics: ASPN 3 – 7 HDSN
As of Nov 16, 2026, Hudson Technologies Inc (HDSN) captures the overall head-to-head institutional edge over Aspen Aerogels, Inc. (ASPN) on higher Unified Composite conviction (53.2/100 HOLD vs. 46.3/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Profitability & Quality), while ASPN wins 4–2 across the 6-pillar growth and valuation breakdown. ASPN trades at $5.14 (N/M Forward P/E, -22.2% operating margin) versus HDSN at $4.25 (25.9x Forward P/E, 2.0% operating margin).
- Growth vs. Quality Trade-Off: HDSN earns the overall head-to-head edge with a stronger Unified Composite Score (53.2/100 HOLD vs. ASPN 46.3/100 HOLD) and 1.32β · 68% Vol risk profile, whereas ASPN leads top-line expansion (+16.7% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
- Technical & Structure Timing Caution: ASPN trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 46.4); meanwhile HDSN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About ASPN vs HDSN
ASPN
Aspen Aerogels, Inc.
$5.14
-7.8% 1D
Market Cap
$456.0M
TTM Revenue
$214M
Forward P/E
N/M
Beta / 30D Vol
1.97β · 124% Vol
Unified Composite Score
46.3
HOLD
Tech 28.0
Fund 43.0
Flow 58.0
Mom 56.0
Weinstein Technical Phase
Neutral · Hold
HDSN
Head-to-Head Winner
Hudson Technologies Inc
$4.25
-3.52% 1D
Market Cap
$186.5M
TTM Revenue
$242M
Forward P/E
25.9x
Beta / 30D Vol
1.32β · 68% Vol
Unified Composite Score
53.2
HOLD
Tech 67.0
Fund 65.0
Flow 55.0
Mom 70.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (ASPN 4 – 2 HDSN)
1. Valuation Multiples
HDSN
Forward P/E
N/M
25.9x
Trailing P/E
N/M
16.5x
PEG Ratio
N/M
0.29x
EV / Revenue
2.0x
0.6x
2. Growth & Scale
ASPN
Revenue Growth (YoY)
+16.7%
-19.7%
Earnings Growth (YoY)
+0.0%
-82.0%
TTM Revenue (USD)
$214M
$242M
Market Cap
$456.0M
$186.5M
3. Profitability & Quality
HDSN
Gross Margin
22.3%
21.0%
Operating Margin
-22.2%
2.0%
Net Profit Margin
-60.8%
-0.5%
Return on Equity (ROE)
-53.2%
-0.5%
4. Balance Sheet & Cash Flow
ASPN
Cash Generation (TTM)
$20M
-$32M
Cash Flow Margin
9.3%
-13.0%
Net Cash / Leverage
$30M Net Cash
$31M Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
ASPN
Options Structure Phase
CONSOLIDATION
BREAKDOWN
Current IV / %ile
41.1% (<1st %ile)
79.1% (15th %ile)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Neutral
ACCUMULATION · Markdown
6. R&D & Supply-Chain Moat
ASPN
OpEx & R&D Intensity
44.5% of Rev ($95M)
19.0% of Rev ($46M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Specialty Chemicals Operator
Specialty Chemicals Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: ASPN (3) vs HDSN (7)| Institutional Metric | ASPN | HDSN | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $456.0M | $186.5M | ASPN | |
| Trailing P/E Ratio | N/M | 16.5x | HDSN | |
| Forward P/E Ratio | N/M | 25.9x | HDSN | |
| Revenue Growth (YoY) | +16.7% | -19.7% | ASPN | |
| Operating Margin (TTM) | -22.2% | 2.0% | HDSN | |
| Net Profit Margin | -60.8% | -0.5% | HDSN | |
| Return on Equity (ROE) | -53.2% | -0.5% | HDSN | |
| 52-Week Range Position | 49% ($2–$8) | 6% ($4–$8) | ASPN | |
| Beta / 30D Volatility | 1.97β · 124% Vol | 1.32β · 68% Vol | HDSN | |
| Unified Institutional Score | 46.3 / 100 (HOLD) | 53.2 / 100 (HOLD) | HDSN | |
| Trailing 12M Revenue (USD) | $214M | $242M | Scale | |
| Gross Profit Margin (TTM) | 22.3% | 21.0% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 2.0x EV/Rev | 0.29x PEG · 0.6x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $20M ($30M Net Cash) | -$32M ($31M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
ASPN +14.4 pp
3M Horizon
ASPN +16.87 pp
6M Horizon
ASPN +10.77 pp
1Y Horizon
ASPN +97.9 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ASPN Revenue | HDSN Revenue | ASPN Op. Margin | HDSN Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $100M | $170M | -32.5% | -25.6% | HDSN |
| FY2019 | $140M | $160M | -10.2% | -9.7% | HDSN |
| FY2020 | $100M | $150M | -21.5% | 4.0% | HDSN |
| FY2021 | $120M | $190M | -33.4% | 21.9% | HDSN |
| FY2022 | $180M | $330M | -43.9% | 40.4% | HDSN |
| FY2023 | $240M | $290M | -20.6% | 27.0% | HDSN |
| FY2024 | $450M | $240M | 12.0% | 12.4% | HDSN |
| FY2025 | $270M | $250M | -139.5% | 7.5% | HDSN |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
ASPN
CONSOLIDATION
Current IV
41.1%
IV Percentile
<1st %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact ASPN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
HDSN
BREAKDOWN
Current IV
79.1%
IV Percentile
15th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
ACCUMULATION
Exact HDSN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
ASPN Moat Profile
Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
OpEx & R&D Reinvestment
44.5% of Rev ($95M)
90D Engineering Disclosures
0 Published
HDSN Moat Profile
Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
OpEx & R&D Reinvestment
19.0% of Rev ($46M)
90D Engineering Disclosures
0 Published
Investor FAQ ASPN vs HDSN Key Questions & Quantitative Answers
As of Nov 16, 2026, Hudson Technologies Inc (HDSN) captures the overall head-to-head institutional edge over Aspen Aerogels, Inc. (ASPN) on higher Unified Composite conviction (53.2/100 HOLD vs. 46.3/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Profitability & Quality), while ASPN wins 4–2 across the 6-pillar growth and valuation breakdown. ASPN trades at $5.14 (N/M Forward P/E, -22.2% operating margin) versus HDSN at $4.25 (25.9x Forward P/E, 2.0% operating margin). Growth vs. Quality Trade-Off: HDSN earns the overall head-to-head edge with a stronger Unified Composite Score (53.2/100 HOLD vs. ASPN 46.3/100 HOLD) and 1.32β · 68% Vol risk profile, whereas ASPN leads top-line expansion (+16.7% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: ASPN trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 46.4); meanwhile HDSN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ASPN leads the Growth & Scale pillar: ASPN posts +16.7% YoY revenue growth and +0.0% YoY earnings growth on $214M TTM revenue (22.3% gross margin, -22.2% operating margin), compared with HDSN at -19.7% YoY revenue growth and -82.0% YoY earnings growth on $242M TTM revenue (21.0% gross margin, 2.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), ASPN cumulative revenue shifted +170.0% while HDSN shifted +47.1%. In operating R&D and SG&A reinvestment, ASPN deploys 44.5% of Rev ($95M) (0 90-day corporate R&D disclosures) versus 19.0% of Rev ($46M) (0 disclosures) for HDSN.
HDSN screens cheaper on headline valuation multiples. ASPN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 2.0x EV/Revenue (9.3% FCF margin), whereas HDSN trades at 25.9x Forward P/E, 16.5x Trailing P/E, 0.29x PEG, and 0.6x EV/Revenue (-13.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ASPN (-53.2% ROE) versus HDSN (-0.5% ROE) capital efficiency.
In options market volatility and institutional positioning, ASPN carries 41.1% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.97β · 124% Vol realized risk). By comparison, HDSN carries 79.1% implied volatility (15th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.32β · 68% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
HDSN vs ASPN · Reverse Pair
ASPN vs TMDX
· Sector Peer
ASPN vs HROW
· Sector Peer
ASPN vs FOUR
· Sector Peer
HDSN vs RCMT
· Sector Peer
HDSN vs HNRG
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem